CClinicalTrials.gg
CompletedNCT06510088Updated Jul 19, 2024

Effects of Multimodal Prehabilitation on Frail Elderly Patients Undergoing Elective Gastric Cancer Surgery

An interventional study of 3-week multimodal prehabilitation program in Elderly, Frail and Gastric Cancer, sponsored by Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University. Completed at 1 site in China. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2024-07-19.

Sponsored by Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 5 years 4 months after the study started (first participant enrolled Mar 2019, registered Jul 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
112
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Research indicates that prehabilitation is effective in optimizing physical status before surgery, although this method may be considered "aggressive" for frail elderly patients. This study aimed to evaluate whether multimodal prehabilitation consisting of preoperative physical therapy, nutritional support, and cognitive exercises decreases postoperative complications and improves functional recovery in frail elderly patients undergoing gastric cancer surgery, in comparison to usual clinical care.

Read the detailed description

Gastric cancer remains a significant health concern globally, especially among elderly individuals, where it poses a considerable burden due to its aggressive nature and limited therapeutic options. Population aging, a result of demographic transition, presents a critical societal challenge. According to a 2022 report by the World Health Organization (WHO), the median age for gastric cancer diagnosis is 69 years, with patients over 75 years facing heightened risks of morbidity and mortality. Although surgical resection remains the primary treatment for gastric cancer, the proportion of elderly patients undergoing surgery declines with age due to preoperative frailty. Frailty, marked by age-related declines in energy, muscle strength, weight, and activity levels, is common among elderly gastric cancer patients and correlates with poorer surgical outcomes, including higher morbidity and mortality. Therefore, interventions aimed at enhancing the functional status and resilience of frail elderly patients undergoing surgery for gastric cancer are critically important.

Numerous studies have demonstrated that prehabilitation can diminish complications, hospital readmissions, length of hospital stay (LOS), and care dependence by enhancing functional reserve. However, these studies did not differentiate between age groups and frailty status, making it difficult to interpret the relationship between the outcomes and advanced age or frailty. It is hypothesized that patients at higher risk for postoperative complications, such as frail elderly individuals, are more likely to benefit from prehabilitation. Nonetheless, conclusive evidence on multimodal rehabilitation specifically designed for this vulnerable population remains insufficient.

Prehabilitation seeks to optimize patients' preoperative risk factors during the waiting period before surgery. This preoperative phase is a critical time to modify health behaviors to reduce the stress of surgery and enhance the recovery process. Multimodal prehabilitation encompasses various interventions, including physical exercise, nutritional optimization, and psychological support, aiming to bolster physiological reserve in anticipation of the expected adverse effects of surgery and to support the postoperative recovery of functional capacity, particularly in patients with lower preoperative fitness levels. Several studies have demonstrated that prehabilitation can diminish complications, hospital readmissions, LOS, and care dependence by enhancing functional reserve. However, during their research, the patients' age group and frailty status were not differentiated, and the relationship between the results and advanced age/frailty cannot be well interpreted. It is hypothesized that patients at higher risk for postoperative complications, such as frail elderly individuals, are more likely to benefit from prehabilitation. Nonetheless, definitive evidence on multimodal rehabilitation specifically tailored to this vulnerable population is lacking.

Therefore, we implemented a randomized clinical trial to provide evidence regarding the potential advantages of multimodal prehabilitation on the outcomes of frail elderly patients undergoing elective gastric cancer surgery.

02

Conditions studied

  • Elderly
  • Frail
  • Gastric Cancer
  • Prehabilitation

Browse trials for

03

In context

Stomach Neoplasms

2,851 studies on the registry are indexed under Stomach Neoplasms; 864 are open to participants now.

This study's enrollment of 112 is above the median of 67 across 2,096 interventional studies indexed under Stomach Neoplasms.

Browse Stomach Neoplasms studies →

Lead sponsor

Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Patients over the age of 65;
  2. Patients with a Fried Frailty Index score of 2 or higher;
  3. Patients who were scheduled for surgical resection of gastric adenocarcinoma;
  4. Patients whose life expectancy was estimated by the surgeon to be greater than six months -

Exclusion criteria

Exclusion Criteria:

Patients were excluded from the study if they:

  1. were scheduled for neoadjuvant therapy;
  2. had metastatic cancer;
  3. were unable to swallow or participate in exercise and fitness assessments due to pre-existing conditions (e.g., orthopedic, neuromuscular, or cardiorespiratory diseases);
  4. had low compliance, defined as executing less than 70% of the weekly plan;
  5. had incomplete data or were lost to follow-up. -
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
112 participants (actual)

Study arms

  • Experimental
    3-week multimodal prehabilitation program+perioperative care guided by ERAS protocols

    This program included four components: aerobic and resistance exercises, respiratory training, nutritional counseling with whey protein supplementation, and psychological adjustment.

    Procedure: 3-week multimodal prehabilitation program

  • No intervention
    perioperative care guided by ERAS protocols

    Perioperative care of the control group was based on standardized ERAS recommendations that have been widely implemented to minimize heterogeneity in perioperative care. Typically, participants did not receive any preoperative interventions related to exercise, nutrition, or mental health.

Interventions

  • Procedure3-week multimodal prehabilitation program

    This program included four components: Aerobic and Resistance Exercises A designated physical therapist supervises the resistance exercises and offers corrective guidance. Training intensity was continuously monitored and fine-tuned based on Borg scale assessments. Respiratory Training Respiratory training was conducted using a respiratory trainer. Patients were instructed to engage in respiratory training at least three times daily, with each session lasting 10 minutes. Nutrition Intervention Those in the multimodal prehabilitation group received daily whey protein powder to ensure a recommended protein intake of 1.5 g/kg/d. Protein supplements were to be consumed within one hour of exercise to promote muscle synthesis. Psychological Intervention Anxiety-coping interventions included relaxation techniques and deep breathing exercises, administered in a one-to-one format by a nurse trained in psychological care.

06

What researchers measure

Primary outcomes

  1. postoperative complications

    30-day postoperative complications assessed by the Comprehensive Complication Index (CCI); The CCI, a validated index for assessing morbidity and mortality, aggregates all complications using the Clavien-Dindo classification system, resulting in a score from 0 (no complications) to 100 (death)

    Time frame: 30-day after surgery

  2. 6-minute walking distance (6MWD)

    Functional capacity was assessed using the 6-MWD, a reliable measure of exercise tolerance in patients undergoing colorectal surgery, with changes of at least 20 meters deemed clinically significant.

    Time frame: 30-day after surgery3-month after surgery

Secondary outcomes

  1. recovery of gastrointestinal function

    recovery of gastrointestinal function

    Time frame: 30 days after surgery

  2. QoL

    QoR-9 scale

    Time frame: 3-month after surgery

  3. physical activity

    Short Form (36) health survey (SF-36)

    Time frame: 3-month after surgery

  4. psychological status

    Hospital Anxiety and Depression scale

    Time frame: 3-month after surgery

07

Study locations

1 site
  • Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University
    Taizhou, Zhejiang, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06510088
Lead sponsor
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
Responsible party
Senbin Lin (General Surgery, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University) — Principal investigator
First posted
Jul 19, 2024
Start date
Mar 1, 2019
Primary completion
Dec 31, 2023
Completion
Dec 31, 2023
Last update
Jul 19, 2024

Study contacts

Senbin Lin
principal investigator · Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion